DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ATIPAMEZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATIPAMEZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
03N9U5JAF6
Molecule Type:
Small molecule
Molecular Formula:
C14H16N2
Molecular Weight:
212.3
AlogP:
2.86
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RAD-140
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
RAD-140
×
Maximum Phase:
1
First Approval:
None
UNII:
4O87Q44KNC
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClN5O2
Molecular Weight:
393.83
AlogP:
3.98
PSA:
118.76
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SULTHIAME
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy
Carbonic anhydrase inhibitor
SULTHIAME
×
Maximum Phase:
1
First Approval:
None
UNII:
I00Q766CZ2
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O4S2
Molecular Weight:
290.37
AlogP:
0.26
PSA:
97.54
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PF-04937319
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Hexokinase type IV activator
PF-04937319
×
Maximum Phase:
1
First Approval:
None
UNII:
7E99B9ZM19
Molecule Type:
Small molecule
Molecular Formula:
C22H20N6O4
Molecular Weight:
432.44
AlogP:
3.38
PSA:
123.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ACHN-975
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACHN-975
×
Maximum Phase:
1
First Approval:
None
UNII:
48CET2EN53
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O4
Molecular Weight:
369.42
AlogP:
0.01
PSA:
124.68
HBD:
5.0
HBA:
#RotB:
5.0
Source:
MINT1526A
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
MINT1526A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RELACATIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RELACATIB
×
Maximum Phase:
1
First Approval:
None
UNII:
BL51M8CB8R
Molecule Type:
Small molecule
Molecular Formula:
C27H32N4O6S
Molecular Weight:
540.64
AlogP:
2.9
PSA:
138.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
BORNEOL
1
Small molecule
Investigational
Unknown
Unknown
Angina, Stable
Unknown
BORNEOL
×
Maximum Phase:
1
First Approval:
None
UNII:
M89NIB437X
Molecule Type:
Small molecule
Molecular Formula:
C10H18O
Molecular Weight:
154.25
AlogP:
2.19
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
DANIQUIDONE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
DANIQUIDONE
×
Maximum Phase:
1
First Approval:
None
UNII:
E780TX33D2
Molecule Type:
Small molecule
Molecular Formula:
C15H11N3O
Molecular Weight:
249.27
AlogP:
2.32
PSA:
58.69
HBD:
1.0
HBA:
#RotB:
0.0
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
MIK-BETA-1
1
Antibody
Investigational
Unknown
Unknown
Leukemia
Interleukin-2 receptor beta chain inhibitor
MIK-BETA-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SGX-523
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
SGX-523
×
Maximum Phase:
1
First Approval:
None
UNII:
WH8SQN09KJ
Molecule Type:
Small molecule
Molecular Formula:
C18H13N7S
Molecular Weight:
359.42
AlogP:
3.22
PSA:
73.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TELRATOLIMOD
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell, Cutaneous
Toll-like receptor 7 agonist
TELRATOLIMOD
×
Maximum Phase:
1
First Approval:
None
UNII:
16598XQ2BT
Molecule Type:
Small molecule
Molecular Formula:
C36H59N5O2
Molecular Weight:
593.9
AlogP:
9.1
PSA:
95.06
HBD:
2.0
HBA:
#RotB:
25.0
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CROLIBULIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Thyroid Neoplasms
Tubulin inhibitor
CROLIBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9ENT43KY91
Molecule Type:
Small molecule
Molecular Formula:
C18H17BrN4O3
Molecular Weight:
417.26
AlogP:
2.85
PSA:
129.54
HBD:
3.0
HBA:
#RotB:
3.0
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-2584702
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Neoplasm Metastasis; Neoplasms; Neuroendocrine Tumors
Ribosomal protein S6 kinase 1 inhibitor
LY-2584702
×
Maximum Phase:
1
First Approval:
None
UNII:
I4965C6W4O
Molecule Type:
Small molecule
Molecular Formula:
C21H19F4N7
Molecular Weight:
445.42
AlogP:
4.3
PSA:
75.52
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MDX-1411
1
Antibody
Investigational
Unknown
Unknown
Lymphoma, Mantle-Cell
CD70 antigen cross-linking agent
MDX-1411
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PP-F11N LUTETIUM LU-177
1
Protein
Investigational
Unknown
Unknown
Thyroid Neoplasms
Unknown
PP-F11N LUTETIUM LU-177
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
C90H120LuN19O35
Molecular Weight:
2204.99
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PHENSERINE, (+)-
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
PHENSERINE, (+)-
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0O4TJ588O
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O2
Molecular Weight:
337.42
AlogP:
3.67
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MIV-818
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIV-818
×
Maximum Phase:
1
First Approval:
None
UNII:
Q1I6YZ0NGF
Molecule Type:
Small molecule
Molecular Formula:
C22H30BrN4O8P
Molecular Weight:
589.38
AlogP:
3.37
PSA:
153.23
HBD:
2.0
HBA:
#RotB:
12.0
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GALEGENIMAB
1
Antibody
Investigational
Unknown
Unknown
Macular Degeneration
Unknown
GALEGENIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-2624587
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY-2624587
×
Maximum Phase:
1
First Approval:
None
UNII:
9T04Q997SD
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PP-F11N LUTETIUM
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
PP-F11N LUTETIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
C90H120LuN19O35
Molecular Weight:
2203.02
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ALOBRESIB
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Lymphoma; Prostatic Neoplasms, Castration-Resistant
Unknown
ALOBRESIB
×
Maximum Phase:
1
First Approval:
None
UNII:
3QBL0BLP3D
Molecule Type:
Small molecule
Molecular Formula:
C26H23N5O2
Molecular Weight:
437.5
AlogP:
4.79
PSA:
100.72
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BUDIGALIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; HIV Infections; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma
Programmed cell death protein 1 inhibitor
BUDIGALIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
6VDO4TY3OO
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
83
84
85
86
87
88
89
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA